Clinical Trial Update: Safety and Efficacy of Irreversible Electroporation in Ablation of Prostate Cancer in Humans [Phase 1]

View source ↗

Summary

Phase 1 trial assessed the safety and preliminary efficacy of irreversible electroporation to ablate prostate cancer in humans, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Irreversible electroporation (IRE) device

Snippet

Sponsor: Clinical Research Office of the Endourological Society | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED